WO2019223218A1 - Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast - Google Patents
Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast Download PDFInfo
- Publication number
- WO2019223218A1 WO2019223218A1 PCT/CN2018/109988 CN2018109988W WO2019223218A1 WO 2019223218 A1 WO2019223218 A1 WO 2019223218A1 CN 2018109988 W CN2018109988 W CN 2018109988W WO 2019223218 A1 WO2019223218 A1 WO 2019223218A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- servings
- chinese medicine
- layer
- traditional chinese
- parts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F7/03—Compresses or poultices for effecting heating or cooling thermophore, i.e. self-heating, e.g. using a chemical reaction
- A61F7/032—Compresses or poultices for effecting heating or cooling thermophore, i.e. self-heating, e.g. using a chemical reaction using oxygen from the air, e.g. pocket-stoves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/008—Magnetotherapy specially adapted for a specific therapy for pain treatment or analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0261—Compresses or poultices for effecting heating or cooling medicated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Definitions
- the invention belongs to the technical field of traditional Chinese medicine patches, and particularly relates to a traditional Chinese medicine transdermal drug delivery patch for promoting blood circulation and collaterals, which is clinically used to treat breast hyperplasia.
- Breast hyperplasia is a breast disease that involves the proliferation of one or more tissues such as acinar epithelium, ductal epithelium, and fibrous connective tissue. It is a non-tumor, non-inflammatory breast epithelial proliferative disorder and belongs to the category of "breast" in Chinese medicine. . The age of onset is concentrated in 20 to 50 years old, and the incidence rate drops sharply after 50 years of age. Its incidence rate is about 40% of women of childbearing age and 75% of all breast diseases. It is the most common breast disease. It is generally believed that the lack of progesterone causes breast hyperplasia and incomplete restoration during the menstrual cycle, and the disease develops over time.
- Traditional Chinese medicine treats this disease with a holistic concept, combining syndrome differentiation with disease differentiation, combining the whole with local treatment, combining internal and external treatment, combining long-term treatment with short-term treatment, and relieving liver qi, promoting blood circulation, dissipating blood stasis, and dissolving, From various aspects and angles, it plays the role of adjusting endocrine and treating both the symptoms and the symptoms.
- the external treatment method of traditional Chinese medicine is aimed at the characteristics of patients with hyperplasia of mammary glands with local symptoms and signs. Using integrated external treatment can directly reach the clinic, which is one of the important ways to treat hyperplasia of mammary glands.
- the transdermal preparation of traditional Chinese medicine of the present invention is a new type of multifunctional therapeutic patch integrating medicinal therapy, warming, magnetic therapy, and hyperthermia, which directly acts on breast lesions with its medicinal therapy, warming, magnetic therapy, and hyperthermia.
- the part can stimulate local breast circulation by stimulating abundant breast blood vessels and meridians or acupoints, and it can clear the meridian, promote blood circulation, soften and loosen the knots, reduce symptoms, and alleviate the pain caused by lobular hyperplasia. , Has an adjuvant therapeutic effect on breast hyperplasia.
- the purpose of the present invention is to provide a traditional Chinese medicine transdermal patch for promoting blood circulation, which can effectively improve the symptoms of breast pain, breast mass, nipple discharge and the like caused by hyperplasia of female breast. Because the drug has the function of promoting blood circulation and collaterals, it also has good curative effects on chronic diseases such as cervical spondylosis, waist and leg pain, chronic strain, spinal pain, rheumatoid arthritis, and osteoarthritis.
- the present invention adopts the following technical solutions:
- a traditional Chinese medicine transdermal patch for promoting blood circulation comprising an adhesive layer, an energy layer, a permanent magnet (magnetized layer), a drug film layer and a backing layer.
- the energy layer is composed of an adhesive layer on its upper surface and The lower surface is covered with an air-impermeable film.
- the inner side of the air-impermeable film is provided with a permanent magnet and a drug film layer, and the permanent magnet is located between the air-impermeable film and the drug film layer.
- the lower surface of the drug film layer is also provided with a layer of release paper to cover the drug film layer and the adhesive layer.
- the inner side of the air-impermeable film refers to the side close to the human skin
- the outer side of the adhesive layer refers to the side far from the human skin.
- the backing layer is made of a breathable non-woven fabric.
- the energy layer contains a heat generating substance.
- the air-impermeable film is made of an air-impermeable material, and the air-impermeable material includes air-impermeable plastic and air-impermeable cloth.
- the medicine film layer is prepared by compounding a traditional Chinese medicine component and a polymer material.
- a traditional Chinese medicine component is coated in a polymer material prepared by compounding polylactic acid and poly3-hydroxybutyrate, and is formulated into a drug film layer.
- the traditional Chinese medicine components in the medicinal film layer are made of the following parts by weight of medicinal materials: 5-7 parts of deer grass, 6-10 parts of fleas, 3-5 parts of peach kernels, 2-4 parts of safflower, and 3-5 parts of frankincense.
- the polymer materials are polylactic acid (PLA) and Poly 3-hydroxybutyrate (PHB).
- the preparation method of the medicine film layer specifically includes the following steps:
- step 3 Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 h to remove the solvent to obtain the drug film layer.
- step 2) the mass ratio of PLA and PHB is (1 ⁇ 5): 5.
- the ratio of the mass of the traditional Chinese medicine component to the total mass of PLA and PHB is 1: 9.
- a traditional Chinese medicine component is coated in a polymer material made of a compound of polylactic acid and poly3-hydroxybutyrate.
- the heating substance contained in the energy layer contacts oxygen and spontaneously generates heat to act on the film.
- Layer which can make the drug release quickly, and because of the coating of the polymer material, the duration of the pharmacological effect is prolonged, maintaining a stable and durable blood drug concentration, while reducing the toxicity and side effects of the drug; on the breast, uterus or joints of the human body
- the pain in the part can have a good therapeutic effect; and as the temperature of the energy layer increases, the volatilization and penetration of each medicinal ingredient in the drug film layer can be promoted, so as to further achieve a good blood circulation and relieve pain. effect;
- a permanent magnet is added to a transdermal patch of traditional Chinese medicine.
- it uses the penetrating effect of its magnetic lines of force to achieve the effects of recuperating and recuperating and regulating qi and blood.
- the thermal magnetic field effect is enhanced, which can excite the medicinal ingredients such as volatile oil contained in the medicinal film layer and decompose them into smaller molecules, thereby helping to promote the transdermal absorption of the medicinal ingredients;
- the traditional Chinese medicine transdermal patch of the present invention integrates medicinal therapy, warm moxibustion, hyperthermia, and magnetic therapy into one body, which can effectively improve the symptoms of breast pain, breast lumps, and nipple discharge caused by breast hyperplasia in women; Pain, chronic strain, spinal pain, rheumatoid arthritis, osteoarthritis and other chronic diseases also have very good effects.
- FIG. 1 is a schematic structural diagram of a transdermal patch of Chinese medicine of the present invention; wherein, 1-adhesive layer, 2-energy layer (containing heat generating substance), 3-permanent magnet (magnetized layer), 4-medicine film layer, 5- Backing layer, 6-airtight film, 7-release paper;
- FIG. 2 is a bottom view of FIG. 1 of the present invention.
- the transdermal patch of Chinese medicine of the present invention includes an adhesive layer 1, an energy layer 2 (containing a heating substance), a permanent magnet (magnetized layer) 3, a drug film layer 4, and a backing layer 5. ;
- the energy layer 2 is covered by an adhesive layer 1 on its upper surface and an air-impermeable film 6 on its lower surface.
- a permanent magnet 3 and a drug film layer 4 are arranged inside the air-impermeable film 6, and the permanent magnet 3 It is located between the air-impermeable film 6 and the medicine film layer 2; a backing layer 5 is provided on the outside of the adhesive layer 1.
- the backing layer 5 is made of a non-woven fabric.
- the air-impermeable film 6 is made of an air-impermeable material, and the air-impermeable material includes air-impermeable plastic and air-impermeable cloth.
- a release paper 7 is provided on the lower surface of the drug film layer 4 to cover the drug film layer 4 and the adhesive layer 1.
- the drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
- step 3 Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.
- the drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
- PLA and PHB were dissolved with ethyl acetate (wherein the mass ratio of PLA and PHB was 1: 1), and each solution was prepared into a 10 wt% solution. The two solutions were mixed at room temperature to obtain a PLA / PHB blend. spare;
- step 3 Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.
- the drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
- step 3 Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Radiology & Medical Imaging (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Immunology (AREA)
Abstract
Description
Claims (10)
- 一种活血通络的中药透皮贴剂,包括粘胶层、能量层、永磁体、药膜层及背衬层,其特征在于:所述能量层由位于其上表面的胶粘层和位于其下表面的不透气膜包覆,所述不透气膜的内侧设有永磁体和药膜层,所述永磁体位于不透气膜和药膜层之间;所述粘胶层的外侧设有背衬层;所述药膜层由中药组分和高分子材料复合制得。A traditional Chinese medicine transdermal patch for activating blood circulation includes a viscose layer, an energy layer, a permanent magnet, a medicine film layer and a backing layer, characterized in that the energy layer consists of an adhesive layer on its upper surface and an adhesive layer on its upper surface. The lower surface is covered with an air-impermeable film. A permanent magnet and a drug film layer are provided on the inner side of the air-impermeable film, and the permanent magnet is located between the air-impermeable film and the drug film layer. The outer side of the adhesive layer is provided. A backing layer; the medicine film layer is prepared by compounding a traditional Chinese medicine component and a polymer material.
- 根据权利要求1所述的中药透皮贴剂,其特征在于:药膜层中的中药组分由以下重量份的药材原料制成:鹿衔草5~7份、 蚤休6~10份、桃仁3~5份、红花2~4份、乳香3~5份、没药3~5份、茜草3~5份、葵蓬菜8-10份、柴胡3~5份、枳壳2~4份、蒲公英4~8份、三棱3~5份、莪术3~5份、漏芦2~4份、山慈菇2~4份、大黄3~5份、干姜2~4份、蜈蜙3~5份、青皮1~3份、全蝎4~6份、水蛭4~6份、雪上一枝蒿1~3份、秦艽1~3份、阿魏2~4份和血竭4~8份。The transdermal patch of traditional Chinese medicine according to claim 1, characterized in that the traditional Chinese medicine component in the medicinal film layer is made of the following parts by weight of medicinal materials: 5-7 parts of deer grass, 6-10 parts of fleas, 3 to 5 servings of peach kernels, 2 to 4 servings of safflower, 3 to 5 servings of frankincense, 3 to 5 servings of myrrh, 3 to 5 servings of madder, 8 to 10 servings of Kwai Peng, 3 to 5 servings of Bupleurum, and 2 shells ~ 4 servings, 4 ~ 8 servings of dandelion, 3 ~ 5 servings of triangular ridge, 3 ~ 5 servings of turmeric, 2 ~ 4 servings of leaked reeds, 2 ~ 4 servings of mountain mushroom, 3 ~ 5 servings of rhubarb, and 2 ~ 4 servings of dried ginger , 3 to 5 servings, 1 to 3 servings of green peel, 4 to 6 servings of whole scorpion, 4 to 6 servings of leech, 1 to 3 servings of Artemisia annua on the snow, 1 to 3 servings of Qin Wei, 2 to 4 servings of fern and blood exhaustion 4 ~ 8 servings.
- 根据权利要求2所述的中药透皮贴剂,其特征在于:所述药膜层中的中药组分的制备方法为:按重量份数计,将鹿衔草5~7份、蚤休6~10份、桃仁3~5份、红花2~4份、乳香3~5份、没药3~5份、茜草3~5份、葵蓬菜8-10份、柴胡3~5份、枳壳2~4份、蒲公英4~8份、三棱3~5份、莪术3~5份、漏芦2~4份、山慈菇2~4份、大黄3~5份、干姜2~4份、蜈蜙3~5份、青皮1~3份、全蝎4~6份、水蛭4~6份、雪上一枝蒿1~3份、秦艽1~3份、阿魏2~4份和血竭4~8份粉碎后,加入其重量3-5倍85wt%的乙醇回流提取2次,每次1小时,合并两次提取液,过滤并回收乙醇;将所得提取液减压浓缩并干燥后,过80-100目筛,得到中药组分。The transdermal patch of traditional Chinese medicine according to claim 2, characterized in that the preparation method of the traditional Chinese medicine component in the medicinal film layer is: by weight parts, 5-7 parts of deer's bite grass, and flea rest 6 ~ 10 servings, 3 ~ 5 servings of peach kernels, 2 ~ 4 servings of safflower, 3 ~ 5 servings of frankincense, 3 ~ 5 servings of myrrh, 3 ~ 5 servings of madder, 8-10 servings of sunflower seeds, 3 ~ 5 servings of bupleurum , 2 ~ 4 servings of coriander shells, 4 ~ 8 servings of dandelion, 3 ~ 5 servings of triangular ridges, 3 ~ 5 servings of turmeric, 2 ~ 4 servings of leaked reeds, 2 ~ 4 servings of mountain mushroom, 3 ~ 5 servings of rhubarb, dried ginger 2 to 4 servings, 3 to 5 servings, 1 to 3 servings of green peel, 4 to 6 servings of scorpion, 4 to 6 servings of leech, 1 to 3 servings of Artemisia annua on the snow, 1 to 3 servings of Qin Wei, 2 to 4 servings of Wei After crushing 4 to 8 parts of blood and 8 parts of blood, add 3-5 times its weight of 85% by weight of ethanol to reflux and extract twice for 1 hour each time. Combine the two extracts, filter and recover the ethanol; concentrate the resulting extract under reduced pressure. After drying, it is sieved through an 80-100 mesh sieve to obtain the traditional Chinese medicine component.
- 根据权利要求1所述的中药透皮贴剂,其特征在于:所述高分子材料为聚乳酸和聚3-羟基丁酸酯。The transdermal patch of traditional Chinese medicine according to claim 1, wherein the polymer material is polylactic acid and poly3-hydroxybutyrate.
- 根据权利要求1所述的中药透皮贴剂,其特征在于:所述药膜层的制备方法具体包括以下步骤:The transdermal patch of Chinese medicine according to claim 1, wherein the method for preparing the medicinal film layer comprises the following steps:1)用乙酸乙酯分别溶解聚乳酸和聚3-羟基丁酸酯,分别配制成8~10wt%的溶液,室温下将两种溶液混合,制得聚乳酸/聚3-羟基丁酸酯共混物,备用;1) Dissolve polylactic acid and poly3-hydroxybutyrate separately with ethyl acetate to prepare 8-10 wt% solutions, and mix the two solutions at room temperature to obtain a polylactic acid / poly-3-hydroxybutyrate co-polymer. Mixture2)取中药组分溶于乙醇中,得到中药液,将所得中药液加入到步骤1)制得的聚乳酸/聚3-羟基丁酸酯共混物中,磁力搅拌6h,浇铸成膜,室温下真空干燥48h以除去溶剂,制得所述药膜层。2) Dissolve the Chinese medicinal components in ethanol to obtain a Chinese medicinal solution, and add the obtained Chinese medicinal solution to the polylactic acid / poly 3-hydroxybutyrate blend prepared in step 1), magnetically stir for 6 hours, and cast into The film was dried under vacuum at room temperature for 48 h to remove the solvent, and the drug film layer was prepared.
- 根据权利要求5所述的中药透皮贴剂,其特征在于:步骤1)中,聚乳酸和聚3-羟基丁酸酯的质量比为(1~5):5。The transdermal patch of Chinese medicine according to claim 5, characterized in that in step 1), the mass ratio of polylactic acid and poly3-hydroxybutyrate is (1 ~ 5): 5.
- 根据权利要求5所述的中药透皮贴剂,其特征在于:所述中药组分的质量与聚乳酸和聚3-羟基丁酸酯总质量的比值为1:9。The transdermal patch of Chinese medicine according to claim 5, characterized in that the ratio of the mass of the Chinese medicine component to the total mass of polylactic acid and poly3-hydroxybutyrate is 1: 9.
- 根据权利要求1所述的中药透皮贴剂,其特征在于:所述背衬层采用透气的无纺布制成。The transdermal patch of traditional Chinese medicine according to claim 1, wherein the backing layer is made of a breathable non-woven fabric.
- 根据权利要求1所述的中药透皮贴剂,其特征在于:所述能量层内含发热物质。The transdermal patch of Chinese medicine according to claim 1, wherein the energy layer contains a heating substance.
- 根据权利要求1所述的中药透皮贴剂,其特征在于:所述药膜层的下表面还设有一层离型纸覆盖在药膜层和粘胶层上。The transdermal patch of traditional Chinese medicine according to claim 1, characterized in that: the lower surface of the medicinal film layer is further provided with a layer of release paper to cover the medicinal film layer and the adhesive layer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810508504.2A CN108404095A (en) | 2018-05-24 | 2018-05-24 | A kind of Chinese medicine transdermal patch promoting blood circulation and removing obstruction in channels for curing mammary gland hyperplasia |
CN201810508504.2 | 2018-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019223218A1 true WO2019223218A1 (en) | 2019-11-28 |
Family
ID=63140450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/109988 WO2019223218A1 (en) | 2018-05-24 | 2018-10-12 | Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN108404095A (en) |
WO (1) | WO2019223218A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108404095A (en) * | 2018-05-24 | 2018-08-17 | 福州鑫美源生物医药工程有限公司 | A kind of Chinese medicine transdermal patch promoting blood circulation and removing obstruction in channels for curing mammary gland hyperplasia |
CN110326827A (en) * | 2019-08-06 | 2019-10-15 | 江苏万鸿健康科技有限公司 | A kind of health care chest pad for preventing and treating the proliferation of mammary gland |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN204133878U (en) * | 2014-10-07 | 2015-02-04 | 胡海帆 | Be used for the treatment of the medical ointment plaster of hysteromyoma and chronic pelvic inflammatory disease |
CN205360237U (en) * | 2016-02-06 | 2016-07-06 | 绍兴易邦医用品有限公司 | Dressing |
CN107648530A (en) * | 2017-11-02 | 2018-02-02 | 青海喜玛拉雅药业有限公司 | Pain relieving plaster |
CN108404095A (en) * | 2018-05-24 | 2018-08-17 | 福州鑫美源生物医药工程有限公司 | A kind of Chinese medicine transdermal patch promoting blood circulation and removing obstruction in channels for curing mammary gland hyperplasia |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102335369A (en) * | 2010-07-22 | 2012-02-01 | 潘立芝 | Traditional Chinese medicinal adhesive plaster for treating mammary gland hyperplasia |
CN102552818A (en) * | 2012-02-15 | 2012-07-11 | 李新民 | External pharmaceutical composition for treating mammary gland diseases and preparation method thereof |
CN104826016B (en) * | 2015-05-14 | 2019-01-29 | 成都市康飞药业有限公司 | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland |
CN107617083A (en) * | 2017-09-14 | 2018-01-23 | 王风连 | Treat the patch of the proliferation of mammary gland |
-
2018
- 2018-05-24 CN CN201810508504.2A patent/CN108404095A/en active Pending
- 2018-10-12 WO PCT/CN2018/109988 patent/WO2019223218A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN204133878U (en) * | 2014-10-07 | 2015-02-04 | 胡海帆 | Be used for the treatment of the medical ointment plaster of hysteromyoma and chronic pelvic inflammatory disease |
CN205360237U (en) * | 2016-02-06 | 2016-07-06 | 绍兴易邦医用品有限公司 | Dressing |
CN107648530A (en) * | 2017-11-02 | 2018-02-02 | 青海喜玛拉雅药业有限公司 | Pain relieving plaster |
CN108404095A (en) * | 2018-05-24 | 2018-08-17 | 福州鑫美源生物医药工程有限公司 | A kind of Chinese medicine transdermal patch promoting blood circulation and removing obstruction in channels for curing mammary gland hyperplasia |
Non-Patent Citations (1)
Title |
---|
WANG, CHUNHUI, ET. AL.: "Analysis of the Prescription Composition Law of TCM External Therapy for the Treatment of Hyperplasia of Mammary Glands", HENAN TRADITIONAL CHINESE MEDICINE, vol. 37, no. 11, pages 2041 - 2044 * |
Also Published As
Publication number | Publication date |
---|---|
CN108404095A (en) | 2018-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110420311A (en) | A kind of asthma moxibustion and preparation method thereof | |
WO2017129132A1 (en) | Healthcare hot compress chinese medicine bag and preparation method for same | |
WO2019223218A1 (en) | Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast | |
CN107998349A (en) | A kind of external application mud moxibustion and preparation method thereof | |
CN106620622A (en) | Moxibustion composition and preparation method and application thereof | |
CN107617083A (en) | Treat the patch of the proliferation of mammary gland | |
CN104888139A (en) | Production method of traditional Chinese medicine moxa stick with effect of breast stagnant blood eliminating | |
CN106963923A (en) | A kind of Chinese medicine composition and preparation method and application with analgesic activity | |
CN104546983B (en) | A kind of primary and secondary emplastrum for treating rheumatism and preparation method | |
CN1132616C (en) | Traditional Chinese medicine for treating arthralgia-syndrome | |
CN109010413A (en) | It is a kind of for female breast lump, breast pain, mazoitis emplastrum | |
CN102078593B (en) | Application of toad peptide antibiotic for preparing medicines for curing diabetic foot | |
CN102423364A (en) | Straightening plaster for treating facial paralysis and preparation method thereof | |
CN111658716A (en) | Hydrogel magnetic therapy traditional Chinese medicine plaster and preparation method thereof | |
CN106109572A (en) | One treats osteoporotic Chinese medicine composition and preparation method thereof | |
CN106139099A (en) | Chinese medicinal ointment for the treatment of neck-shoulder pain, lumbago and leg pain and preparation method thereof | |
CN101518579B (en) | Pressure stabilizing deoppilant and preparation process | |
CN101628063A (en) | Externally-applied plaster for treating synovitis | |
CN105125798A (en) | Plaster and preparation method thereof | |
CN110755578A (en) | External traditional Chinese medicine for treating plantar wart and preparation method thereof | |
CN108514573A (en) | A kind of topical Chinese medicine plaster and Chinese medicine lotion for external use drug paste | |
CN103961618A (en) | Plaster for treating pains caused by wind-cold damp pathogens | |
CN109432060A (en) | A kind of moxibustion patch and preparation method thereof for treating cough due to wind-cold evil | |
CN115040574B (en) | Traditional Chinese medicine composition and traditional Chinese medicine preparation for treating thyroid nodule and preparation method thereof | |
CN106955314A (en) | Heat-clearing river Huang of invigorating blood circulation dissipates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18920057 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18920057 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18920057 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18920057 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 04/03/2022) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18920057 Country of ref document: EP Kind code of ref document: A1 |